Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Oxford Immunotec Global PLC (OXFD)

« Back to company index

OXFD Chatter Timeline

Stock Ticker for OXFD

Most Active Tweeters for OXFD

UserTweets
@dakotafinancial 6
@AmericanBanking 5
@dispatchtribune 5
@macondailynews 4
@stocknewstimes 4

Recent Tweets for OXFD

dakotafinancial @dakotafinancial
Oxford Immunotec Global PLC $OXFD Expected to Post Quarterly Sales of $13.88 Million https://t.co/7mAvewbvjQ
March 21st 2019, 7:03pm
Briefingcom @Briefingcom
$OXFD: Oxford Immunotec announces retirement of CFO Richard Altieri, effective April 30, and appoints Matthew... https://t.co/Zwd9ZvzuWW
March 21st 2019, 6:03pm
WatchlistN @WatchlistN
Oxford Immunotec Global $OXFD Downgraded by Zacks Investment Research https://t.co/NJoEgbFuAV
March 21st 2019, 6:03am
ConsumerFeed @ConsumerFeed
Oxford Immunotec Global $OXFD Lifted to “Buy” at Zacks Investment Research https://t.co/aSCobjO1Ej
March 21st 2019, 5:03am
OlympiaReport @OlympiaReport
Oxford Immunotec Global $OXFD Downgraded to Hold at Zacks Investment Research https://t.co/O1daqgAU6h
March 20th 2019, 10:03am
WeekHerald @WeekHerald
Zacks Investment Research Downgrades Oxford Immunotec Global $OXFD to Hold https://t.co/hw22OFBK9p
March 20th 2019, 10:03am
TickerReport @TickerReport
Oxford Immunotec Global PLC $OXFD Expected to Post Earnings of -$0.20 Per Share https://t.co/dRyx6NLQ8T
March 19th 2019, 2:03pm
WatchlistN @WatchlistN
Oxford Immunotec Global PLC $OXFD Expected to Post Quarterly Sales of $13.88 Million https://t.co/DGhB4Vj5cH
March 19th 2019, 2:03pm
bbnsnews @bbnsnews
Oxford Immunotec Global $OXFD Cut to Hold at Zacks Investment Research https://t.co/zorSdoXHLc
March 19th 2019, 6:03am
Briefingcom @Briefingcom
$OXFD: Oxford Immunotec files to delay its 10-K citing sale of its U.S. laboratory services business to Quest... https://t.co/HI4FC6TfJA
March 18th 2019, 7:03pm
FinZTribune @FinZTribune
Big Money Are Not Betting On Oxford Immunotec Global PLC $OXFD, Sentiment at 1.08 https://t.co/tQNmhIOWqT
March 18th 2019, 11:03am
whatsonthorold2 @whatsonthorold2
Oxford Immunotec Global PLC $OXFD 2018 Q4 Sentiment Report https://t.co/3ALquNyylO
March 17th 2019, 4:03pm
thefinreviewer @thefinreviewer
Cortina Asset Management Lowered Oxford Immunotec Global Plc $OXFD Position; Myovant Sciences LTD.HARES $MYOV SI In… https://t.co/GhIzBtymsk
March 17th 2019, 2:03pm
ArizetSignals @ArizetSignals
17 MAR 2019 - Week's Top Gainers $OXFD @ $18.20 1-Week Return: 15.48% Combined Score: -15.0 Sentiment: BEARISH Conf… https://t.co/Ihy2TDc8To
March 17th 2019, 1:03pm
WatchlistN @WatchlistN
-$0.20 Earnings Per Share Expected for Oxford Immunotec Global PLC $OXFD This Quarter https://t.co/SzuQoEVWGu
March 17th 2019, 11:03am
TickerReport @TickerReport
Oxford Immunotec Global PLC $OXFD Expected to Post Quarterly Sales of $13.88 Million https://t.co/pBZCUeJp3d
March 17th 2019, 11:03am
dailypoliticaln @dailypoliticaln
Analysts Anticipate Oxford Immunotec Global PLC $OXFD Will Post Quarterly Sales of $13.88 Million https://t.co/rQvRBpEXW8
March 17th 2019, 11:03am
ConsumerFeed @ConsumerFeed
Oxford Immunotec Global $OXFD Upgraded at Zacks Investment Research https://t.co/gHQu6eoy1M
March 17th 2019, 5:03am
WeekHerald @WeekHerald
Oxford Immunotec Global $OXFD Lifted to Buy at Zacks Investment Research https://t.co/yuUxs3oRu3
March 16th 2019, 9:03am
ThisLincolnian @ThisLincolnian
Oxford Immunotec Global $OXFD Stock Rating Upgraded by Zacks Investment Research https://t.co/iRERfHrNXQ
March 16th 2019, 9:03am
bbnsnews @bbnsnews
Brokers Set Expectations for Oxford Immunotec Global PLC’s Q1 2019 Earnings $OXFD https://t.co/TI56nzwfrm
March 16th 2019, 2:03am
registrarjourn @registrarjourn
Oxford Immunotec Global $OXFD Downgraded by ValuEngine https://t.co/pcJVFDxGK3
March 15th 2019, 1:03pm
EnterpriseLeade @EnterpriseLeade
Oxford Immunotec Global $OXFD Downgraded by ValuEngine https://t.co/YF4BvzHmGa
March 15th 2019, 1:03pm
dispatchtribune @dispatchtribune
Oxford Immunotec Global $OXFD Downgraded to “Buy” at ValuEngine https://t.co/WKjEeSK0CQ
March 15th 2019, 1:03pm
dispatchtribune @dispatchtribune
Oxford Immunotec Global $OXFD Raised to “Buy” at Zacks Investment Research https://t.co/oAuteWUZkQ
March 15th 2019, 8:03am
TranscriptDaily @TranscriptDaily
Brokerages Expect Oxford Immunotec Global PLC $OXFD to Announce -$0.20 EPS https://t.co/wDaJxPm1nJ
March 15th 2019, 5:03am
stocknewstimes @stocknewstimes
Analysts Anticipate Oxford Immunotec Global PLC $OXFD Will Announce Earnings of -$0.20 Per Share https://t.co/9YKVzF9Wtn
March 15th 2019, 5:03am
dispatchtribune @dispatchtribune
Q1 2019 Earnings Estimate for Oxford Immunotec Global PLC $OXFD Issued By Piper Jaffray Companies https://t.co/PaBPt5YUoM
March 15th 2019, 1:03am
OlympiaReport @OlympiaReport
Q1 2019 Earnings Estimate for Oxford Immunotec Global PLC $OXFD Issued By Piper Jaffray Companies https://t.co/j2tfS6hxAR
March 15th 2019, 1:03am
TheMarketsDaily @TheMarketsDaily
Zacks Investment Research Upgrades Oxford Immunotec Global $OXFD to “Buy” https://t.co/ig62Wka0YX
March 14th 2019, 12:03pm
macondailynews @macondailynews
Oxford Immunotec Global $OXFD Upgraded to “Buy” at Zacks Investment Research https://t.co/L2urjDdbcp
March 14th 2019, 12:03pm
TheMarketsDaily @TheMarketsDaily
Q1 2019 EPS Estimates for Oxford Immunotec Global PLC Lifted by Analyst $OXFD https://t.co/AszUhLU2MI
March 14th 2019, 6:03am
macondailynews @macondailynews
Q1 2019 EPS Estimates for Oxford Immunotec Global PLC Lifted by Analyst $OXFD https://t.co/7Q1YfRSmvP
March 14th 2019, 6:03am
AmericanBanking @AmericanBanking
Q1 2019 EPS Estimates for Oxford Immunotec Global PLC Lifted by Analyst $OXFD https://t.co/8fnwPN54mF #stocks
March 14th 2019, 6:03am
AmericanBanking @AmericanBanking
Zacks: Analysts Anticipate Oxford Immunotec Global PLC $OXFD Will Post Quarterly Sales of $13.89 Million https://t.co/cx2Gcgq6Ue #stocks
March 14th 2019, 3:03am
WeekHerald @WeekHerald
Zacks: Analysts Anticipate Oxford Immunotec Global PLC $OXFD Will Post Quarterly Sales of $13.89 Million https://t.co/qePLQfdGCB
March 14th 2019, 3:03am
ThisLincolnian @ThisLincolnian
$13.89 Million in Sales Expected for Oxford Immunotec Global PLC $OXFD This Quarter https://t.co/BwLP0hr190
March 14th 2019, 3:03am
ConsumerFeed @ConsumerFeed
Oxford Immunotec Global $OXFD Downgraded to Buy at ValuEngine https://t.co/NnTiv9Knu8
March 14th 2019, 1:03am
thefinreviewer @thefinreviewer
Consonance Capital Management LP Continues to Hold Holding in Oxford Immunotec Global Plc $OXFD; Dafna Capital Mana… https://t.co/yoTwTG4Ge9
March 13th 2019, 3:03pm
OlympiaReport @OlympiaReport
Oxford Immunotec Global $OXFD Posts Quarterly Earnings Results, Beats Expectations By $1.44 EPS https://t.co/4Db7Aec84x
March 13th 2019, 1:03pm
dispatchtribune @dispatchtribune
Oxford Immunotec Global $OXFD Releases Earnings Results, Beats Expectations By $1.44 EPS https://t.co/2VzHPHJFBE
March 13th 2019, 12:03pm
ResearchPool @ResearchPool
$OXFD #Oxford Immunotec Global Oxford Immunotec - FY18 results focus on TB: FY18 was a transformational year for Ox… https://t.co/Sls1vdr3RX
March 13th 2019, 9:03am
PredatorDiaries @PredatorDiaries
My latest note on $OXFD's FY18 results - a growing TB diagnostic product and maiden profit. What's not to like? https://t.co/LzlDN1VkjC
March 13th 2019, 9:03am
TickerReport @TickerReport
Oxford Immunotec Global $OXFD Lowered to Buy at ValuEngine https://t.co/kzKIj2vga4
March 13th 2019, 7:03am
WatchlistN @WatchlistN
Oxford Immunotec Global $OXFD Lowered to Buy at ValuEngine https://t.co/YWU3vLB4IF
March 13th 2019, 7:03am
TranscriptDaily @TranscriptDaily
Oxford Immunotec Global $OXFD Stock Rating Upgraded by Zacks Investment Research https://t.co/IiN2IdzkVn
March 13th 2019, 6:03am
dailypoliticaln @dailypoliticaln
Oxford Immunotec Global $OXFD Trading Up 7.5% on Strong Earnings https://t.co/seH4yISztr
March 13th 2019, 2:03am
ZolmaxNews @ZolmaxNews
Oxford Immunotec Global $OXFD Shares Up 7.5% Following Better-Than-Expected Earnings https://t.co/h31h9feNPa
March 13th 2019, 2:03am
mmahotstuff1 @mmahotstuff1
BTIG Reiterated Oxford Immunotec $OXFD As a "Buy"; They Now Have a Price Objective Of $21 https://t.co/KhGxukpK9Q
March 13th 2019, 1:03am
whatsonthorold2 @whatsonthorold2
Oxford Immunotec $OXFD "Buy" Rating Reaffirmed Today By BTIG; The Target Price per Share is Set to $21 https://t.co/D3Whtf6Bhc
March 13th 2019, 1:03am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.